Search research articles
Contact Us
Filters
Showing results (131-140 of 161) with videos related to
Page
of 17
Sort By:
Immunopharmacology
|
October 17, 1998
Effects of a novel purine nucleoside phosphorylase inhibitor, BCX-34, on activation and proliferation of normal human lymphoid cells
R M Conry, S Bantia, H S Turner, et al.
Clinical and Experimental Immunology
|
September 1, 1993
In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees
M Jonker, W Slingerland, G Treacy, et al.
Cancer Research
|
August 25, 1991
Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons
J W Greiner, F Guadagni, D Goldstein, et al.
American Journal of Obstetrics and Gynecology
|
August 1, 1986
Radioimmunoassay of free beta-subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancy
M B Khazaeli, M M Hedayat, K D Hatch, et al.
Cancer
|
March 1, 1984
Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group study
M K Samson, S E Rivkin, S E Jones, et al.
Cancer Research
|
July 15, 1995
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin
K Dhingra, H Fritsche, J L Murray, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 1992
Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer
R F Meredith, M B Khazaeli, T Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1995
Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancer
R F Meredith, M B Khazaeli, W E Plott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1996
Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer
R F Meredith, M B Khazaeli, W E Plott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
M S Czuczman, A J Grillo-López, P McLaughlin, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 161) with videos related to
Sort By:
Page
of 17
Immunopharmacology
|
October 17, 1998
Effects of a novel purine nucleoside phosphorylase inhibitor, BCX-34, on activation and proliferation of normal human lymphoid cells
R M Conry, S Bantia, H S Turner, et al.
Clinical and Experimental Immunology
|
September 1, 1993
In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees
M Jonker, W Slingerland, G Treacy, et al.
Cancer Research
|
August 25, 1991
Evidence for the elevation of serum carcinoembryonic antigen and tumor-associated glycoprotein-72 levels in patients administered interferons
J W Greiner, F Guadagni, D Goldstein, et al.
American Journal of Obstetrics and Gynecology
|
August 1, 1986
Radioimmunoassay of free beta-subunit of human chorionic gonadotropin as a prognostic test for persistent trophoblastic disease in molar pregnancy
M B Khazaeli, M M Hedayat, K D Hatch, et al.
Cancer
|
March 1, 1984
Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group study
M K Samson, S E Rivkin, S E Jones, et al.
Cancer Research
|
July 15, 1995
Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin
K Dhingra, H Fritsche, J L Murray, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 1992
Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer
R F Meredith, M B Khazaeli, T Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 1, 1995
Initial clinical evaluation of iodine-125-labeled chimeric 17-1A for metastatic colon cancer
R F Meredith, M B Khazaeli, W E Plott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1996
Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer
R F Meredith, M B Khazaeli, W E Plott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
M S Czuczman, A J Grillo-López, P McLaughlin, et al.
Page
of 17